Product Details
Product Name:
Capzimin |
CAS No.:
2084868-04-0 |
Purity:
98.31% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | Capzimin |
Description | Capzimin is a selective inhibitor of proteasome isopeptidase Rpn11. |
In vitro | In leukemia cells, Capzimin exhibits GI50s of 0.67 μM and 1 μM in SR and K562 cell lines. For non-small cell lung cancer, Capzimin exhibits a GI50 of 0.7 μM in NCI-H460. For breast cancer, Capzimin exhibits a GI50 of 1.0 μM in MCF7. Capzimin blocks cell growth and induces apoptosis in HCT116 cells[1]. |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 50.1 mg/mL (79.7 mM)
|
Keywords | Capzimin |
Related Compound Libraries | Bioactive Compound Library | Inhibitor Library | Bioactive Compounds Library Max | Covalent Inhibitor Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:514-85-2
$494.00 / 5mg
-
CAS:113712-98-4
$47.00 / 10mg
-
CAS:2169919-21-3
$67.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$51.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |